COVID-19: Vaccine and Monoclonal Antibody Update

FDA Revokes Monoclonal Antibody AuthorizationsПодробнее

FDA Revokes Monoclonal Antibody Authorizations

TWiV 1154: Clinical update with Dr. Daniel GriffinПодробнее

TWiV 1154: Clinical update with Dr. Daniel Griffin

Vaccines vs Monoclonal Antibodies for COVID-19: Complementary Approaches to Tackling the PandemicПодробнее

Vaccines vs Monoclonal Antibodies for COVID-19: Complementary Approaches to Tackling the Pandemic

COVID-19, Flu, and RSV: A 2024 Update from the CDCПодробнее

COVID-19, Flu, and RSV: A 2024 Update from the CDC

Next-Generation Monoclonal Antibodies for COVID-19: A Clinical UpdateПодробнее

Next-Generation Monoclonal Antibodies for COVID-19: A Clinical Update

CDC COVID-19 vaccine guidelines: When is the new COVID vaccine coming out in 2024?Подробнее

CDC COVID-19 vaccine guidelines: When is the new COVID vaccine coming out in 2024?

A New Monoclonal Antibody for Covid-19 and Potential Vaccination for ChildrenПодробнее

A New Monoclonal Antibody for Covid-19 and Potential Vaccination for Children

Monoclonal Antibodies and Vaccine BoostsПодробнее

Monoclonal Antibodies and Vaccine Boosts

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 TreatmentПодробнее

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 Treatment

Covid, Flu & RSV; Measles Status Update: New COVID Prevention / Monoclonal (Pemgarda)Подробнее

Covid, Flu & RSV; Measles Status Update: New COVID Prevention / Monoclonal (Pemgarda)

TWiV 934: Clinical update with Dr. Daniel GriffinПодробнее

TWiV 934: Clinical update with Dr. Daniel Griffin

TWiV 988: Clinical update with Dr. Daniel GriffinПодробнее

TWiV 988: Clinical update with Dr. Daniel Griffin

Webinar: Progress in RSV vaccines and monoclonal antibodiesПодробнее

Webinar: Progress in RSV vaccines and monoclonal antibodies

Monoclonal Antibodies as COVID-19 Prophylaxis in Immunocompromised PatientsПодробнее

Monoclonal Antibodies as COVID-19 Prophylaxis in Immunocompromised Patients

TWIV 1088: Clinical update with Dr. Daniel GriffinПодробнее

TWIV 1088: Clinical update with Dr. Daniel Griffin

Invivyd, Inc - Development of a Monoclonal Antibody for COVID-19 Prevention in Vulnerable PopulatioПодробнее

Invivyd, Inc - Development of a Monoclonal Antibody for COVID-19 Prevention in Vulnerable Populatio

Immunocompromised patients and Immune escape - COVID-19 vaccines update 69Подробнее

Immunocompromised patients and Immune escape - COVID-19 vaccines update 69

New variants XBB + BQ.1.1 next wave predictions - COVID-19 vaccines update 75Подробнее

New variants XBB + BQ.1.1 next wave predictions - COVID-19 vaccines update 75

Next Generation Covid 19 Vaccine, Monoclonal Antibodies & Nasal Vaccine InnovationsПодробнее

Next Generation Covid 19 Vaccine, Monoclonal Antibodies & Nasal Vaccine Innovations

HIV Vaccines and Monoclonal Antibodies – What’s Taking So Long and WhyПодробнее

HIV Vaccines and Monoclonal Antibodies – What’s Taking So Long and Why